Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease
Clinical Journal of the American Society of Nephrology, ISSN: 1555-905X, Vol: 5, Issue: 6, Page: 972-984
2010
- 94Citations
- 61Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations94
- Citation Indexes94
- 94
- CrossRef89
- Captures61
- Readers61
- 61
- Mentions2
- News Mentions2
- 2
Most Recent News
Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease
Djalila Mekahli 1,2 na1, Max C. Liebau ORCID: orcid.org/0000-0003-0494-90803 na1, Melissa A. Cadnapaphornchai ORCID: orcid.org/0000-0002-0460-24774, Stuart L. Goldstein ORCID: orcid.org/0000-0003-3711-87855, Larry A. Greenbaum
Article Description
Background and objectives: Renal function and imaging findings have not been comprehensively and prospectively characterized in a broad age range of patients with molecularly confirmed autosomal recessive polycystic kidney disease (ARPKD). Design, setting, participants, & measurements: Ninety potential ARPKD patients were examined at the National Institutes of Health Clinical Center. Seventy-three fulfilled clinical diagnostic criteria, had at least one PKHD1 mutation, and were prospectively evaluated using magnetic resonance imaging (MRI), high-resolution ultrasonography (HR-USG), and measures of glomerular and tubular function. Results: Among 31 perinatally symptomatic patients, 25% required renal replacement therapy by age 11 years; among 42 patients who became symptomatic beyond 1 month (nonperinatal), 25% required kidney transplantation by age 32 years. Creatinine clearance (CrCl) for nonperinatal patients (103 ± 54 ml/min/1.73 m2) was greater than for perinatal patients (62 ± 33) (P = 0.002). Corticomedullary involvement on HR-USG was associated with a significantly worse mean CrCl (61 ± 32) in comparison with medullary involvement only (131 ± 46) (P < 0.0001). Among children with enlarged kidneys, volume correlated inversely with function, although with wide variability. Severity of PKHD1 mutations did not determine kidney size or function. In 35% of patients with medullary-only abnormalities, standard ultrasound was normal and the pathology was detectable with HR-USG. Conclusions: In ARPKD, perinatal presentation and corticomedullary involvement are associated with faster progression of kidney disease. Mild ARPKD is best detected by HR-USG. Considerable variability occurs that is not explained by the type of PKHD1 mutation. Copyright © 2010 by the American Society of Nephrology.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77953304171&origin=inward; http://dx.doi.org/10.2215/cjn.07141009; https://clinicaltrials.gov/ct2/show/NCT00068224; http://www.ncbi.nlm.nih.gov/pubmed/20413436; https://journals.lww.com/01277230-201006000-00005; http://cjasn.asnjournals.org/cgi/doi/10.2215/CJN.07141009; https://syndication.highwire.org/content/doi/10.2215/CJN.07141009; https://dx.doi.org/10.2215/cjn.07141009; https://journals.lww.com/cjasn/fulltext/2010/06000/correlation_of_kidney_function,_volume_and_imaging.5.aspx; https://journals.lww.com/cjasn/Fulltext/2010/06000/Correlation_of_Kidney_Function,_Volume_and_Imaging.5.aspx; https://cjasn.asnjournals.org/content/5/6/972; https://cjasn.asnjournals.org/content/5/6/972.abstract; https://cjasn.asnjournals.org/content/5/6/972.full.pdf; http://cjasn.asnjournals.org/lookup/doi/10.2215/CJN.07141009; https://cjasn.asnjournals.org/content/clinjasn/5/6/972.full.pdf; http://cjasn.asnjournals.org/content/5/6/972
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know